Intervention
Cardiac monitoring
ClinicalTrials.gov intervention label
Clinical trials
2 shownTrial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.NCT06754553 · 2025-02-01
NOT_YET_RECRUITINGRandomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.NCT03947216 · 2020-10-23
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED1
NOT_YET_RECRUITING1
Phase mix
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.